ma] immunoassays
provide an alternative to other recent types of immunoassay.
Each liposome can entrap many molecules of measured substance, giving a potential amplification of signal in an immunoassay.
If the entrapped material is a sensitive marker (e.g., fluorophore), liposomal immunoassays have potential for increased sensitivity.
The use of an intense chromogen (e.g., dye), on the other hand, can produce a simple and rapid assay by direct spectrophotometric measurement, provided a color change occurs when the chromogen is released. Cardiolipin-containing liposomes have long been shown to be destabilized in the presence of divalent cations [8] . Janoff et al., in 1983, reported a change of color when liposomes containing the dye arsenazo III were lysed by magnesium ions [7] . The liposomal lysis and release of dye was found to be inhibited by systemic lupus erythematosus (SLE) serum. 3 The procedure was essentially qualitative although the amount of color change could be measured by a spectrophotometer.
The nature of the antibodies causing this inhibition was not established in the report; in 1983, the range of antibodies found in SLE sera had not been clearly elucidated.
After the development of specific anticardiolipin antibody (ACA) assays involving RIA and ELISA [9, 10] ,ACAs are now known to exist as a discrete population of antibodies (although there appears to be overlap in reactivity in some cases with other SLE antibodies such as anti-doublestranded DNA). Distinct prognostic roles of ACA antibodies in SLE have also been established.
IgG ACAs are a class of antiphospholipid antibodies (APAs) found in a subgroup of patients at risk of thrombosis, recurrent fetal loss, and thrombocytopenia [11] [12] [13] with an antibody concentration of 1100 GPL units [GPL unit is the unit of activity (IgG; MPL for 1gM) of a standardized affinity-purified serum from a patient [10] ]. This was diluted in a serum pool to establish a calibration curve. To minimize the antibody concentration present in the pool, samples (n = 100) from patients without evidence of immunological disorders were collected.
The 20 samples with the lowest lysis by MgCI2, assessed on the Cobas Bio, were combined and used subsequently as a "negative pool" for dilution of the ACA-positive serum. 
ELISAS

Results
Assessed by gel filtration, entrapment of dye (-21%) in the cardiolipin-containing liposomes was similar to that found previously in liposomes not incorporating cardiolipin but otherwise prepared under similar conditions [4] . The effect of addition of ACA on the Mg (II) ion-dependent absorption change is shown in Fig. 1 At physiological concentrations, magnesium ions and calcium ions did not cause detectable dye release. The liposomal ACA assay was configured as a two-step assay. This provided a check of any liposomal lysis by human complement, which would have resulted in a high absorbance after the preincubation relative to the other cuvettes. No such anomalous absorbance changes were observed. In preparing the diluent pool for calibrants in the liposomal assay, samples with low absorbance changes were selected to minimize ACAs. It is still likely that a small amount of antibodies was present, although the absorbance change due to the pool was only 0.018, which was low compared with that of added ACA (Fig. 1) . The lowest absorbance change in any of these Table 2 . The differences between the normalized mean values for the two sources of samples (i.e., blood donor and antenatal clinic attendera) were not significant by two-sample t-tests (Table 3) , except for the difference between the ELISA results for the two sources of samples, which was weakly significant (P <0.05). By using combined data for the two groups of samples, a square-roottransformed reference range of 1.1-19.9 GPL units was obtained for the liposomal assay and 1.9-20.5 GPL units for the ELISA. For comparison, the range for 5th to 95th percentiles was 2. 8-16.5 GPL units for the liposomal assay and 4.2-18.5 GPL units for the ELISA.
COMPARISON OF IMPRECISIONS
Since in ELISA the tests are normally assayed in duplicate, the samples were assayed on the Cobas in the same way. The Cobas performs tests by using rotors with a maximum capacity of 24 tests per sample tray. The ELISA imprecision was calculated from results obtained from a single microtiter plate. Samples could be analyzed on the Cobas either in a similar way to the ELISA method, i.e., with calibrators in the same rotor, or with a calibration curve in an earlier rotor, provided there was little drift in results from rotor to rotor. To assess both these options, imprecisions were calculated within a single rotor and also over three rotors. The results are shown in Fig. 3 . The imprecisions were similar, except that over three rotors the Table 3 . AnalysIs of significance of dIfferences In means (from Table 2 ). Cobas performed considerably worse at low antibody concentrations.
LIMITS OF DETECTION
The limits of detections were estimated as equal to 3 SD of a value close to zero, calculated from the imprecisions of the lowest pool (-5 GPL units). The limits of detections were 2 GPL units for ELISA and also 2 GPL units for the within-rotor liposomal assay, and 4 GPL units for the liposomal assay over three rotors.
Discussion
On the face of it, the augmenting of liposomal lysis by ACAs is contradictory to the report of Janoff et al. [7] . Their assay showed inhibition of liposomal lysis by SLE serum. However, both the preparation of liposomes and the reaction conditions used by Janoff et al. differed from this study, and some of these differences are compared in Table 4 . As the procedures varied so markedly, it is perhaps not surprising that dissimilar effects were observed. Unfortunately it is not possible to estimate the relative amounts of liposomes used in the two techniques, since the liposome dilution of Janoff et al. was not indicated.
No antibody-dependent change in lysis rate was found in the absence of cardiolipin, even though PTA, which like cardiolipin is a negatively charged lipid, was present in the liposomes. This
This report
Reverse evaporation -200 nm [11] 1:25 (Table 1 accords with the view that lysis is specific for cardiolipin. Significant liposomal lysis was observed in this study only in the presence of both ACAS and Mg (II) ions, suggesting that under these assay conditions, their combination is necessary for any degree of liposomal lysis.
The colorimetric assay of Janoff et a]. [7] was based on the reaction of released dye with magnesium ions external to the liposome.
A similar ion-dependent color change has been reported for the chromogen 2-(2-thiazolylazo)-4-methyl-5-(sulfomethylamino)benzoic acid (TAMSMB), which reacts with chromium (III) ions [16] .As previously described [4] , the use of su]forhodamine B as a marker is potentially simpler and more robust, since the color change is solely dependent on the dye's dilution and not on a second reactant (e.g., ion) concentration.
Compared
with ELISA, the sample dilution in the liposomal assay is much lower. The use of a greater amount of serum in the assay might have a beneficial effect compared with ELISA, since the concentration of 132-glycoprotein I (32-GP1), a cofactor, is also much greater. There has been considerable recent debate over the role of 2-GPI since its involvement in binding ACAS was first suggested by Galli et al. [17] . The claim that f32-GPI was the agent to which ACAS bind, rather than cardiolipin, sparked controversy. Their findings were apparently supported by the detection of APAs by using an ELISA with 132-GPI as antigen [18] , but may have been due to trace amounts of phospholipid contaminants in 132-GPI preparations [19] [20] [21] or nonspecific binding to plates [22] . It now appears that p2-GPI at least enhances ACA binding to cardiolipin bound to microtiter plates and the antigen seems to be a complex of cardiolipin and 2-GPI.
It is probable that adequate f32-GPI was present in the liposomal immunoassay.
The addition of animal serum is necessary in ELISAS, which involve large predilutions of sera. [25, 26] . Nevertheless, the liposomal assay has advantages because of its simplicity, greater assay speed (a few minutes compared with several hours), and ease of automation.
A liposomal technique could be valuable in rapid preliminary tests for IgG ACAS, perhaps enabling wider study of the incidence of these antibodies. The assay may also facilitate preliminary investigations in smaller laboratories whose workload is too small to justify on-site testing by ELISA at present. One potential clinical application that might benefit from a method for rapid screening of risk populations was suggested by the study of Hamsten et a]. [27] . They found that raised IgG ACAS were associated with a high risk of recurrent cardiovascular events in postmyocardial infarction patients. ACAS were also shown in postmyocardial infarction patients in another small study [28] . However, no influence of raised ACAS soon after myocardial infarct on immediate patient outcome was reported in other studies [29, 30] .A liposomal assay may have a role in helping to reconcile these conflicting findings, which may be due to different selected populations, timing of samples relative to the myocardial event, and durations of study.
